Range
- - -
Vol / Avg.
-/565.1K
Div / Yield
-
52 Wk
0.12 - 19.73
Mkt Cap
326.2M
Payout Ratio
-
Open
-
P/E
-
EPS
-1.83
Shares
21.1M
Outstanding
21.1M
Total Float
14.2M
Benzinga - Jun 15, 2021, 8:07AM
Benzinga - Jun 8, 2021, 8:15AM
Benzinga - May 24, 2021, 6:12AM
Benzinga - May 18, 2021, 9:51AM
Benzinga - May 12, 2021, 2:02PM
Benzinga - May 12, 2021, 7:03AM
Benzinga - Apr 27, 2021, 2:13PM
Benzinga - Apr 19, 2021, 8:00AM
Benzinga - Apr 19, 2021, 7:17AM
Benzinga - Apr 13, 2021, 7:37AM
Benzinga - Apr 13, 2021, 7:08AM
Benzinga - Apr 12, 2021, 8:06AM
Benzinga - Apr 8, 2021, 8:01AM
load more
Sector: Health Care.Industry: Biotechnology
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-1.830
REV0
Q4 2020Est.ActualSurprise
EPS-0.240-3.400 -3.1600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GTBPGT Biopharma-1.23%326.2M

GT Biopharma Frequently Asked Questions

Q

How do I buy GT Biopharma (GTBP) stock?

A

You can purchase shares of GT Biopharma (NASDAQ: GTBP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are GT Biopharma's (GTBP) competitors?

A

Other companies in GT Biopharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Aeglea BioTherapeutics (NASDAQ:AGLE), Fortress Biotech (NASDAQ:FBIO), 89bio (NASDAQ:ETNB) and Adverum Biotechnologies (NASDAQ:ADVM).

Q

What is the target price for GT Biopharma (GTBP) stock?

A

The latest price target for GT Biopharma (NASDAQ: GTBP) was reported by HC Wainwright & Co. on May 24, 2021. The analyst firm set a price target for 25.00 expecting GTBP to rise to within 12 months (a possible 61.92% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for GT Biopharma (GTBP)?

A

The stock price for GT Biopharma (NASDAQ: GTBP) is $15.44 last updated Tue Jun 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does GT Biopharma (GTBP) pay a dividend?

A

There are no upcoming dividends for GT Biopharma.

Q

When is GT Biopharma (NASDAQ:GTBP) reporting earnings?

A
GT Biopharma’s Q1 earnings are confirmed for after-market on May 17, 2021.
Q

Is GT Biopharma (GTBP) going to split?

A

There is no upcoming split for GT Biopharma.

Q

What sector and industry does GT Biopharma (GTBP) operate in?

A

GT Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.